Yen-Ju Lin

Cells · 2020

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Yen-Ju Lin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. N. Borregaard
  2. M. Pescovitz
  3. J. Smolen
  4. K. Redlich
  5. B. Bartok
  6. Daniel Aletaha

Papers from Yen-Ju Lin's perspective

Ordered by how strongly the researchers Yen-Ju Lin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. New therapies for treatment of rheumatoid arthritis. (The Lancet)
  2. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. (New England Journal of Medicine)
  3. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. (American Journal of Pathology)
  4. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007 (Arthritis & Rheumatism)
  5. Inflammatory bone loss: pathogenesis and therapeutic intervention (Nature reviews. Drug discovery)
  6. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving… (Arthritis & Rheumatism)
  7. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. (Arthritis & Rheumatism)
  8. Evidence that cytokines play a role in rheumatoid arthritis. (Journal of Clinical Investigation)
  9. IL-23-IL-17 immune axis: Discovery, Mechanistic Understanding, and Clinical Testing
  10. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease (Nature Medicine)

Their papers